Ananda Ghosh
Stock Analyst at H.C. Wainwright
(4.21)
# 1,804
Out of 4,421 analysts
100
Total ratings
42%
Success rate
15.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Rated: Buy | $100 → $70 | $44.51 | +57.27% | 19 | Jun 11, 2026 | |
| PEPG PepGen | Reiterated: Buy | $20 | $1.79 | +1,017.32% | 11 | May 29, 2026 | |
| SKYE Skye Bioscience | Maintained: Buy | $20 | $0.7073 | +2,727.65% | 7 | May 21, 2026 | |
| DYN Dyne Therapeutics | Maintained: Buy | $50 | $19.80 | +152.53% | 9 | May 21, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $110 | $25.68 | +328.35% | 18 | May 20, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $12 | $1.89 | +534.92% | 8 | May 14, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | $50 | $31.00 | +61.29% | 10 | May 8, 2026 | |
| ANNX Annexon | Maintained: Buy | $14 | $4.90 | +185.71% | 5 | May 8, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $37 | $21.62 | +71.14% | 9 | May 7, 2026 | |
| IVA Inventiva | Maintained: Buy | $24 | $3.57 | +572.27% | 4 | Jan 28, 2026 |
Structure Therapeutics
Jun 11, 2026
Rated: Buy
Price Target: $100 → $70
Current: $44.51
Upside: +57.27%
PepGen
May 29, 2026
Reiterated: Buy
Price Target: $20
Current: $1.79
Upside: +1,017.32%
Skye Bioscience
May 21, 2026
Maintained: Buy
Price Target: $20
Current: $0.7073
Upside: +2,727.65%
Dyne Therapeutics
May 21, 2026
Maintained: Buy
Price Target: $50
Current: $19.80
Upside: +152.53%
Maze Therapeutics
May 20, 2026
Maintained: Buy
Price Target: $110
Current: $25.68
Upside: +328.35%
ProQR Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $12
Current: $1.89
Upside: +534.92%
Stoke Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $50
Current: $31.00
Upside: +61.29%
Annexon
May 8, 2026
Maintained: Buy
Price Target: $14
Current: $4.90
Upside: +185.71%
ACADIA Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $37
Current: $21.62
Upside: +71.14%
Inventiva
Jan 28, 2026
Maintained: Buy
Price Target: $24
Current: $3.57
Upside: +572.27%